Sandoz Canada is led by a diverse team with extensive experience in the pharmaceutical industry.
Michel Robidoux has been President and General Manager of Sandoz Canada since 2010 and has nearly 30 years of experience in the pharmaceutical, generics, consumer, and medical devices industry. Under his leadership, Sandoz Canada has become one of the fastest-growing pharmaceutical companies in Canada while broadening its portfolio beyond generics to include specialty pharma, biosimilars, and OTC products. Sandoz has an engaged workforce of more than 900 employees in Boucherville and was one of Canada’s top 100 employers in 2017.
Mr. Robidoux originally joined Sandoz Canada as Vice President, Sales in 2008. For more than 10 years before joining Sandoz/Novartis, Mr. Robidoux held the position of Vice President at Roche for different business units within the company such as Diabetes Care, Professional Diagnostics, Molecular Diagnostics, and Applied Science. Prior to Roche, he worked at Bayer for 7 years in various sales and marketing roles of increasing responsibility.
He is an active contributor to the industry as a member of the Canadian Generic Pharmaceutical Association (CGPA), the Chairman of the CGPA Biosimilars Committee, an active member of the Board of Directors of the Canadian Association for Pharmacy Distribution Management (CAPDM), as well as a member of Board of the Centre Laurent Beaudoin. Mr. Robidoux holds a Bachelor’s degree in Business Administration from the Université du Québec à Montreal.
Daniel Abran is the Executive Director, Commercial Operations Quality, and has been working for Sandoz Canada since February 2007. As such, his duties include quality assurance for business development, product recall and complaint management, and handling establishment licences and quality contracts. He is also in charge of releasing contract manufactured and imported product batches for the Canadian market and monitoring the compliance of some 80+ manufacturing sites in the Sandoz Canada supply chain.
Mr. Abran began his career as the owner of the research and development consulting firm, D.A. LAB Inc., and then went on to become Senior Scientist and Pharmacology Manager at Theratechnologies Inc.
He has a PhD in Anatomy from Dalhousie University in Halifax and did his post-doctoral research on neurotransmitters and the cardiovascular system at the Research Centre of the Sainte-Justine Hospital in Montreal. He is the author of more than 40 articles and book chapters, and holds three patents.
Martin has more than 25 years of experience working for global organizations in the retail, medical devices and pharmaceutical industries. Before joining Sandoz Canada, he was Vice President, Diabetes & Cardiovascular business unit, at Sanofi Pharmaceutical, based in Montreal. He began his career with Glaxo Canada in Montreal and subsequently held senior positions, including in sales, account management and marketing, with such companies as Johnson & Johnson, Roche, Analogic Corporation and Bristol-Myers Squibb.
M. Arès holds a bachelor’s degree in Finance and Marketing from HEC Montréal and has also completed several professional development programs in finance, leadership and marketing, among others.
Len Arsenault has over 30 years of regulatory affairs experience in the pharmaceutical industry, including more than 11 years with the Therapeutic Products Directorate, spent mostly within the Bureau of Pharmaceutical Quality where he was manager of the Oral Products Division at the time of his departure. He continued on to Rhoxal Pharma to hold executive positions of Director of Regulatory Affairs and Reseach, followed by Vice-President Regulatory Affairs and Development. Len Arsenault joined Sandoz Canada in 2005 as Vice-President of Scientific Affairs, where he is responsible for the Regulatory Competency Center as well as the Intellectual Property group. He is also Chair of the Canadian Generic Pharmaceutical Association Scientific Affairs committee and sits on the CGPA Intellectual Property Committee.
Mr. Arsenault holds a Bachelor’s degree in Chemistry from Concordia University.
Jocelyn Binet has been Executive Director, Integrity and Compliance, Commercial Operations, since January 2018. Before joining Sandoz in 2017, he was Director of Inquiries and Syndic at the Ordre des pharmaciens du Québec. He also worked as a legal director, corporate secretary and legal consultant at Eli Lilly Canada.
Mr. Binet holds degrees in pharmacy and law
Mark Boehmer is Vice President Business Development & Portfolio since February 2017. He has worked in our industry for more than 25 years and is a pharmacist with hospital and community experience. He was most recently (since 2011) Vice President, Pharmaceutical Procurement, at the Katz Group, where he was responsible for managing the generic program for Rexall Pharmacy and gained a vast experience with Canadian pharmaceutical products.
Prior to Katz, M. Boehmer worked for several well-known pharmaceutical companies, including Merck Frosst Canada, Eli Lilly Canada and Schering Canada, before joining Patheon Inc. as Senior Manager, Pharmaceutical Development Services, in 1996. Over the following 15 years, he held increasingly senior positions with this leading global provider of outsourced drug development and manufacturing.
He holds a BSc (Chemistry) and Bachelor of Pharmacy from the University of Manitoba and an MBA from McMaster University, Michael G. DeGroote School of Business.
Marc Boisvert has been Vice President, Supply Chain/External Partners since 2017. He joined Sandoz in 2002 and has vast experience and knowledge in production and supply chain management.
Mr. Boisvert holds an executive MBA, a Graduate Diploma in International Administration and a Bachelor’s in Operations Management and International Management.
Vincenzo Ciampi has been Executive Director, Innovation and Strategic Projects since 2016.
Mr. Ciampi brings more than 20 years of experience in business development, marketing, corporate strategy and change management with major corporations in the insurance, IT, financial and health service sectors. His previous positions have included Director, Strategic Projects, at CGI; Vice President, Strategy and Corporate Development as well as Vice President, External Communications and Public Affairs, at Standard Life Assurance; and Vice President, Corporate Marketing at Aon Hewitt. Prior to joining Sandoz Canada, he was General Manager, Strategy and Product Management, at Telus Health.
Mr. Ciampi holds a Bachelor of Commerce degree in Marketing/International Business from McGill University and a MBA from École des Hautes Études Commerciales.
François David joined Sandoz in Octobre 2016. He has a broad experience in the world of Consumer Products. He has had several important mandates during his career, including managing the nation-wide activities of pharmaceutical and medical sales departments, trade marketing, telemarketing, sales, and more. Before joining Pendopharm, he was the National Commercial Director of Pierre Fabre Dermo-Cosmétique Canada. Previously, he was a senior Brand Manager at Molson Coors Canada and Director of Local Sales of Montréal NRJ and Rock Détente for Astral Media Radio Québec. He also worked for nine years for Johnson & Johnson Canada, one of the top 3 businesses in OTC, as National Director of Sales (RoC), Product Director – Professional Marketing, Product Director – Stayfree and K-Y brands, and Product Manager – Neutrogena brand.
He has a Bachelor’s degree in Administration with a concentration in Marketing from the Université de Sherbrooke and has completed several specialized educational programs.
Martin Fournier has been Vice-President Finance and CFO since 2015. He joined Sandoz in 2006 as Director, Information and Financial Accounting. He has over 17 years of diverse project management experience in the field of accounting and finance, mainly within businesses in the manufacturing sector. Before joining Sandoz, he held various positions in accounting firms at the auditing and consulting levels, most recently at Deloitte as Senior Director, Management and Technology Consulting.
Mr. Fournier holds a Bachelor’s degree in Accounting, B.B.A., from Hautes Études Commerciales Montréal. He is also a member of the Ordre des comptables agréés du Québec.
Karine Matteau leads the Biosimilar business segment and the growth of Sandoz’ portfolio of biosimilar products in various therapeutic fields. Ms. Matteau has over 20 years of experience in the pharmaceutical industry in various commercial strategic roles. She joined Novartis in 2007 and in the last 11 years, she has had a successful path through various commercial roles in multiple general medicine and specialty divisions. In her last mandates, she assumed leadership positions in Sales & Marketing within the Novartis Oncology division. Prior to Novartis, she held various commercial positions at Sanofi-Aventis Canada, mainly in CV & Metabolism/Diabetes.
Karine Matteau’s academic background includes an MBA from HEC Montreal and a Bachelor of Science from McGill University.
Isabelle Robitaille has been Executive Director, Legal Affairs and General Counsel since February 2018.
Ms. Robitaille joined Sandoz in 2014 and is an expert in the fields of business and commercial law, mergers and acquisitions, and intellectual property rights.
She holds a Bachelor of Law from the Université de Sherbrooke and has 20 years of experience in transactional law, including more than 15 years in the pharmaceutical industry.
Marc St-Pierre holds the position of Vice-president, Human Resources. He joined Sandoz (previously Sabex) in 1997 and, as business partner, his main responsibilities are to oversee the HR strategic orientation and policy alignment for the canadian operations (including the Development Centre, Manufacturing, the Quality Unit and Commercial operations). With over 25 years' experience in the field of Human Resources management, he has previously held several management positions in industry leading companies, more specifically in the publishing/direct mail business (with Reader's Digest) as well as telecommunications (with Canadian Marconi Company).
Mr. St-Pierre holds a Bachelor's degree in Industrial Relations from the Université du Québec en Outaouais and is a member of the Ordre des conseillers en ressources humaines agréés (CHRP).
Isabelle is Executive Director, Communications and is responsible for managing internal, corporate and brand image communications, as well as supporting grants, donations and sponsorships.
Isabelle has 20 years of experience in strategic communications, working in international corporations (Environmental Resources Management and Aimia) and global leading public relations agencies (such as Edelman, Fleishman-Hillard, Optimum/Cossette) in Canada and Europe. During her career, she has led marketing and corporate communications strategies for private and public organizations, as well as associations facing various issues, in multiple industry sectors including healthcare. She has dedicated her broad expertise and global perspective to help inform, convince, inspire and engage organizations’ internal and external publics.
Isabelle graduated from ESC Rouen business school in France in 1997 and holds an Accreditation in Business Communications (ABC) from the International Association of Business Communicators (IABC) where she has held different active roles.